Follow the MiniMed Group, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2bn. The latest transaction was reported on 4 August 2026 (Retenue fiscale). Among the most active insiders: Dallara Que. Every trade is openly available.
26
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate MiniMed Group, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$58.59.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
MiniMed Group, Inc. is a NASDAQ-listed company that specializes in developing technologies for diabetes management. It focuses on glucose monitoring systems and insulin pumps.